BIOGEN INC. Logo

BIOGEN INC.

Biotechnology company developing therapies for neurological and neurodegenerative diseases.

BIIB | US

Overview

Corporate Details

ISIN(s):
US09062X1037
LEI:
Country:
United States of America
Address:
225 BINNEY STREET, 2142 CAMBRIDGE

Description

Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-03 17:42
PRIMARY DOCUMENT
English 7.3 KB
2025-11-13 21:28 English 8.6 KB
2025-11-04 17:12
PRIMARY DOCUMENT
English 7.1 KB
2025-10-30 07:31
10-Q
English 4.8 MB
2025-10-30 07:13
8-K
English 185.6 KB
2025-10-14 18:19
8-K
English 80.9 KB
2025-10-06 15:00
PRIMARY DOCUMENT
English 7.0 KB
2025-09-02 19:56
PRIMARY DOCUMENT
English 7.3 KB
2025-09-02 14:54 English 7.0 KB
2025-07-31 08:13
8-K
English 177.3 KB
2025-07-31 08:05
10-Q
English 4.7 MB
2025-07-30 19:56 English 8.3 KB
2025-07-21 23:18 English 9.8 KB
2025-07-16 19:55
PRIMARY DOCUMENT
English 6.5 KB
2025-07-08 17:26 English 6.9 KB

Automate Your Workflow. Get a real-time feed of all BIOGEN INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOGEN INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOGEN INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.